Evidence map›Paper›PMID 26023183›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Transcription factor PRDM8 is required for rod bipolar and type 2 OFF-cone bipolar cell survival and amacrine subtype identity.

Cynthia C Jung, Denize Atan, David Ng, Lynda Ploder, Sarah E Ross, Martin Klein, David G Birch, Eduardo Diez, Roderick R McInnes

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The second family affected with a PRDM8-related disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Generation and characterization of Lhx4Genesis (New York, N.Y. : 2000) · 2019
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Cynthia C JungDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5G 1X8; Program in Developmental Biology, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8;
Denize AtanDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5G 1X8; Program in Developmental Biology, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8; Academic Department of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol BS8 1TD, United Kingdom;
David NgDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5G 1X8; Program in Developmental Biology, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8;
Lynda PloderDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5G 1X8; Program in Developmental Biology, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8;
Sarah E RossDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA 15213; Department of Anesthesiology, University of Pittsburgh, Pittsburgh, PA 15213; Center for Pain Research, University of Pittsburgh, Pittsburgh, PA 15213;
Martin KleinRetina Foundation of the Southwest, Dallas, TX 75231;
David G BirchRetina Foundation of the Southwest, Dallas, TX 75231;
Eduardo DiezLady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada H3T 1E2;
Roderick R McInnesDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5G 1X8; Program in Developmental Biology, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8; Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada H3T 1E2; Department of Human Genetics, McGill University, Montreal, QC, Canada H3A 1B1; Department of Biochemistry, McGill University, Montreal, QC, Canada H3G 1Y6 rod.mcinnes@mcgill.ca.
Hospital for Sick Children · CARetina Foundation of the Southwest · USUniversity of Toronto · CAJewish General Hospital · CAMcGill University · CAUniversity of Pittsburgh · US

Funding

Investigating the Neural Circuits of ItchR01AR063772 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI H Richard Koerber, Sarah Elizabeth Ross · 2013 to 2026
$6.9M
Using dual intersectional genetics to understand and modulate itchR21AR064445 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROSS, SARAH ELIZABETH · 2013 to 2014
$358k
Canadian Institutes of Health Research IOP-54037Canadian Institutes of Health Research MOP-7315NIAMS NIH HHS R01 AR063772NIAMS NIH HHS R01AR063772NIAMS NIH HHS R21 AR064445NIAMS NIH HHS R21AR064445Wellcome TrustWellcome Trust WT084585
6 · The paper itself

Abstract

Retinal bipolar (BP) cells mediate the earliest steps in image processing in the visual system, but the genetic pathways that regulate their development and function are incompletely known. We identified PRDI-BF1 and RIZ homology domain containing 8 (PRDM8) as a highly conserved transcription factor that is abundantly expressed in mouse retina. During development and in maturity, PRDM8 is expressed strongly in BP cells and a fraction of amacrine and ganglion cells. To determine whether Prdm8 is essential to BP cell development or physiology, we targeted the gene in mice. Prdm8(EGFP/EGFP) mice showed nonprogressive b-wave deficits on electroretinograms, consistent with compromised BP cell function or circuitry resembling the incomplete form of human congenital stationary night blindness (CSNB). BP cell specification was normal in Prdm8(EGFP/EGFP) retina as determined by VSX2(+) cell numbers and retinal morphology at postnatal day 6. BP subtype differentiation was impaired, however, as indicated by absent or diminished expression of BP subtype-specific markers, including the putative PRDM8 regulatory target PKCα (Prkca) and its protein. By adulthood, rod bipolar (RB) and type 2 OFF-cone bipolar (CB) cells were nearly absent from Prdm8-null mice. Although no change was detected in total amacrine cell (AC) numbers, increased PRKCA(+) and cholinergic ACs and decreased GABAergic ACs were seen, suggesting an alteration in amacrine subtype identity. These findings establish that PRDM8 is required for RB and type 2 OFF-CB cell survival and amacrine subtype identity, and they present PRDM8 as a candidate gene for human CSNB.

Indexed as

Amacrine CellsAnimalsCell SurvivalDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseHistone MethyltransferasesMiceMice, TransgenicRetinal Bipolar CellsRetinal Cone Photoreceptor CellsRetinal Rod Photoreceptor CellsDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseHistone MethyltransferasesPRDM8 protein, mouseamacrine cellbipolar celldevelopmentgeneticsretina

Identifiers

PMID26023183
PMCPMC4466745
OpenAlexW2099335261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.